Pages

Friday, May 1, 2020

Google Alert - in

Google
in
As-it-happens update 1 May 2020
NEWS
Unemployed workers in these states may find themselves ineligible for jobless benefits under certain circumstances. Ultimately, states, which administer ...
Facebook Twitter Flag as irrelevant
But both Cook and Apple CFO Luca Maestri gave quite a bit of color on a call with analysts about what they've seen economically in response to Covid- ...
Facebook Twitter Flag as irrelevant
Dan Ives: 'This is a small victory in a dark environment' on Apple Q2 earnings. Dan Ives, Wedbush managing director and Ross Gerber, Gerber ...
Facebook Twitter Flag as irrelevant
"We despair that many more will follow, particularly in places least able to cope". He ran through the multiple ways the Organization is working to combat ...
Facebook Twitter Flag as irrelevant
The number is a full 80 percent higher than Facebook's non-ad revenue in 2019's first quarter, suggesting that the niche VR industry could be on the rise.
Facebook Twitter Flag as irrelevant
Seven new cases of coronavirus were confirmed in Victoria on Thursday, with the chief health officer, Professor Brett Sutton, revealing a cluster had ...
Facebook Twitter Flag as irrelevant
They are deemed essential. The Connor Group operates higher-end apartments in 14 markets. So, the company called an all-staff meeting disguised as ...
Facebook Twitter Flag as irrelevant
Let's put it in food terms: Reopening will not be a quick sear. It will be a low and slow simmer that will take weeks or possibly months to roll out. Gov. Gary ...
Facebook Twitter Flag as irrelevant
Oregon's 102nd reported COVID-19 death is a 69-year-old man in Multnomah County, who tested positive April 7 and died on April 26 at Legacy ...
Facebook Twitter Flag as irrelevant
On Wednesday, the KDHE reported 3,738 cases in Kansas, 364 cases in Sedgwick County and 125 deaths statewide. The Sedgwick County Health ...
Facebook Twitter Flag as irrelevant
WEB
BioNTech and Pfizer dose participants in Covid-19 vaccine trial
BioNTech and Pfizer have dosed participants in the first cohort of a Phase I/II clinical trial of Covid-19 vaccine candidate, BNT162, in Germany.
Facebook Twitter Flag as irrelevant
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback
ShareThis

No comments:

Post a Comment